This guidance document focuses on the diagnosis and treatment of venous
thromboembolism (VTE). Efficient, cost effective diagnosis of VTE is facilitated by combining …

Background Since hypercoagulability might result in recurrent miscarriage, anticoagulant
agents could potentially increase the chance of live birth in subsequent pregnancies in …

Background The use of anticoagulant therapy during pregnancy is challenging because of
the potential for both fetal and maternal complications. This guideline focuses on the …

Venous thromboembolism (VTE), which may manifest as pulmonary embolism (PE) or deep
vein thrombosis (DVT), is a serious and potentially fatal condition. Treatment and prevention …

The guideline was drafted by a writing group identified by the Haemostasis and Thrombosis
Task Force of the British Committee for Standards in Haematology (BCSH). All the authors …

Background: Early‐onset hypertensive disorders (HD) of pregnancy and small‐for‐
gestational age infants (SGA) are associated with placental vascular thrombosis, these often …

Background Venous thromboembolism (VTE), although rare, is a major cause of maternal
mortality and morbidity, and methods of prophylaxis are therefore often used for women …

Therapeutic options for the management of venous thromboembolism (VTE) in patients with
cancer remain very limited. Although low-molecular-weight heparin monotherapy has been …

The main reason for the increased risk of thromboembolism in pregnancy is
hypercoagulability, which has likely evolved to protect women from the bleeding challenges …

Introduction There is no accepted consensus on thromboprophylaxis in relation to in vitro
fertilization (IVF). We aimed to study the frequency of thromboembolism and to assess …